Tag Archives: Matthew Sharpe CFA

Morgan Stanley Reaffirms Their Buy Rating on Booz Allen (BAH)

Morgan Stanley analyst Matthew Sharpe CFA maintained a Buy rating on Booz Allen (BAH – Research Report) today and set a price target of $84.00. The company’s shares closed last Tuesday at $75.80. According to TipRanks.com, CFA is a 3-star

General Dynamics (GD): New Sell Recommendation for This Technology Giant

Morgan Stanley analyst Matthew Sharpe CFA maintained a Sell rating on General Dynamics (GD – Research Report) today and set a price target of $151.00. The company’s shares closed last Tuesday at $139.84. According to TipRanks.com, CFA is a 3-star

L3Harris Technologies (LHX) Receives a Buy from Morgan Stanley

Morgan Stanley analyst Matthew Sharpe CFA maintained a Buy rating on L3Harris Technologies (LHX – Research Report) today and set a price target of $252.00. The company’s shares closed last Tuesday at $196.30. According to TipRanks.com, CFA is a 3-star

Analysts Offer Insights on Conglomerates Companies: Northrop (NYSE: NOC) and Xylem (NYSE: XYL)

Companies in the Conglomerates sector have received a lot of coverage today as analysts weigh in on Northrop (NOC – Research Report) and Xylem (XYL – Research Report). Northrop (NOC) In a report released today, Matthew Sharpe CFA from Morgan

Perspecta (PRSP) Gets a Hold Rating from Morgan Stanley

In a report released yesterday, Matthew Sharpe CFA from Morgan Stanley maintained a Hold rating on Perspecta (PRSP – Research Report), with a price target of $20.00. The company’s shares closed last Monday at $17.07. According to TipRanks.com, CFA is

New Buy Rating for Northrop (NOC), the Technology Giant

Morgan Stanley analyst Matthew Sharpe CFA maintained a Buy rating on Northrop (NOC – Research Report) yesterday and set a price target of $380.00. The company’s shares closed last Monday at $281.28, close to its 52-week low of $263.29. According